Dr. Natasha Paul, lead biologist, commented, "This grant demonstrates TriLink's continued focus on solving molecular biology problems through chemistry."
TriLink's CEO, Richard Hogrefe stated, "TriLink is first and foremost a research and development team. We are committed to our science, as well as supporting our customers' scientific advancements, and are confident we will soon offer a number of novel ligation products to compliment our CleanAmp PCR line of products."
About TriLink
TriLink manufactures custom oligonucleotides, modified nucleoside triphosphates and CleanAmp PCR products for the diagnostic and OEM markets. In addition, custom chemistry, contract research services and ISO/QSR compliant cGMP production facilities are offered. TriLink's solutions help advance drug discovery and biomedical research. Founded in 1996, TriLink is a privately held firm based in San Diego, California and employs approximately 85 scientists and other professionals. For more information about the firm and products, call 858-546-0004, email info@trilinkbiotech.com, or visit our web site at www.trilinkbiotech.com.
SOURCE TriLink BioTechnologies, Inc.